Abstract

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women

Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol

Issue: Jul/Aug 2008 - Hormone Replacement Therapy

Page(s): 295-304

Download in electronic PDF format for $75
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 1
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 2
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 3
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 4
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 5
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 6
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 7
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 8
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 9
  • Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Page 10

Abstract

Conventional hormone replacement therapy increases a woman’s risk of thrombotic events as evidenced in large prospective clinical trials, including HERS I and the Women’s Health Initiative. A possible mechanism for this is the unfavorable net effects of conjugated equine estrogens and medroxyprogesterone acetate on factors involved in hemostatic balance and inflammation. The objective of this study was to examine the short-term effects of transdermal progesterone on menopausal symptoms and serum levels of hemostatic, inflammatory, and immune signaling factors. In a prospective, randomized, double-blinded, placebo-controlled, crossover study, 30 healthy postmenopausal women received either 20 mg/day of transdermal progesterone or placebo for 4 weeks, followed by a 4-week washout period, and were then crossed over to receive either placebo or active drug for an additional 4 weeks. Baseline, 4-week follow-up, and end-of-study values were obtained for the Greene Climacteric Scale, and for serum levels of total fa

Related Keywords

  • women
  • menopause
  • transdermal administration
  • topical preparations
  • hormone replacement therapy
  • HRT
  • progesterone
  • Women's Health Initiative
  • WHI
  • blood clots
  • inflammation
  • cardiovascular disorders
  • heart disease
  • thrombosis
  • hemostatic factors
  • coagulation

Related Categories

  • HRT
  • ADVERSE DRUG EVENTS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Sep/Oct 2003
Pg. 330-338
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Author(s): Gillson George R, Zava David T
Jan/Feb 2004
Pg. 16-21
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Author(s): Cutter Christopher B
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Mar/Apr 2004
Pg. 96-99
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Author(s): Cutter Christopher B
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Mar/Apr 2023
Pg. 108-112
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Mar/Apr 2010
Pg. 165-170
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Author(s): Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Jul/Aug 2003
Pg. 250-256
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Author(s): Gillson George R, Zava David T
Jan/Feb 2017
Pg. 6-16
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Author(s): Deleruyelle Laura J
Jan/Feb 2014
Pg. 70-77
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Author(s): Ruiz Andres D, Daniels Kelly R
Sep/Oct 1999
Pg. 357-359
Women's Health Book Reviews
Author(s): Reed-Kane Dana
Mar/Apr 2002
Pg. 142-146
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Author(s): Wepfer Scott T
Mar/Apr 2012
Pg. 110-114
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Author(s): Griffee Chris, Delano Amy
Nov/Dec 2020
Pg. 466-470
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1
Author(s): DeRosa Angela
Jul/Aug 2009
Pg. 345-349
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia
Author(s): Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
Jul/Aug 2007
Pg. 292-296
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Author(s): Holt-Waldo NaRisa Y, Stephenson Kenna